3rdPartyFeeds

Top Research Reports for Amazon, Walmart & UnitedHealth

Top Research Reports for Amazon, Walmart & UnitedHealth Read More...

Tuesday, December 22, 2020

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Amazon.com (AMZN), Walmart (WMT) and UnitedHealth Group (UNH). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Amazon shares have outperformed the broader market in the year to date period (+73.5% vs. +16.6%) on the back of solid Prime momentum and leadership in the cloud computing space. 

Further, coronavirus-led spike in online orders continues to be a major tailwind. Also, solid growth in its online stores sales remains a positive. Moreover, surge in online grocery shopping is another positive. Additionally, strong adoption rate of AWS is aiding the company’s cloud dominance.

Moreover, expanding AWS services portfolio is continuously helping Amazon in gaining further momentum among the customers. Further, improving Alexa skills and expanding smart home products portfolio are positives. However, accelerating coronavirus related expenses remain risks for the company’s margin expansion in the near term. Also, rising cloud competition poses risk. 

(You can read the full research report on Amazon here >>>)

Shares of Walmart have gained +22.6% over the past year against the Zacks Supermarkets industry’s gain of +20.9%. The Zacks analyst believes that the company is gaining on rising demand for grocery and general merchandise amid the pandemic.

Stay-at-home trends are also boosting e-commerce sales, which soared 79% in the U.S. segment in third-quarter fiscal 2021. During the quarter, the top and bottom lines beat the estimates and grew year over year, with U.S. comp sales rising for the 25th straight time. Comps were fueled by strength in core categories and higher shift toward e-commerce.

Clearly, Walmart’s efforts to enhance deliveries are yielding results. Also, the company is focused on improving the International unit’s performance, evident from its recent plans to sell certain businesses. However, the company is seeing high COVID-19 costs, which are likely to prevail. Also, price investments are hurting gross margin to an extent.

(You can read the full research report on Walmart here >>>)

UnitedHealth’s shares have gained +12.9% over the past six months against the Zacks Medical Insurance industry’s rise of +10.2%. The Zacks analyst believes that expansion of the company’s health services segment provides significant diversification benefits.

UnitedHealth remains well poised to benefit from its government business, comprising both Medicaid and Medicare Advantage. A solid balance sheet and consistent cash flow generation not only encourage investments in business but also add shareholder value. Raising of 2020 earnings guidance instills investor confidence.

However, the company is witnessing a slowdown in its international operations. Increased joblessness stemming from the COVID-19 induced volatilities might hurt Commercial membership.

(You can read the full research report on UnitedHealth here >>>)

Other noteworthy reports we are featuring today include Intel (INTC), Morgan Stanley (MS) and GlaxoSmithKline (GSK).

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>

Sheraz Mian

Director of Research                                                                                              

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today’s Must Read

Prime Momentum & Growing AWS Adoption Benefit Amazon (AMZN)

Walmart’s (WMT) Sales to Gain on Robust Ecommerce Business

Strong Service and Benefit Business Aids UnitedHealth (UNH)

Featured Reports

Intel (INTC) Banks on Portfolio Strength Amid 7 nm Delay

Per the Zacks analyst, solid uptake of thelatest Xeon Scalable processors, and demand from cloud service providers will drive Intel’s growth.

Buyout, Restructuring Aid Morgan Stanley (MS) Amid Low Rates

Per the Zacks analyst, Morgan Stanley’s inorganic growth efforts and focus on less capital-markets dependent businesses will likely continue to aid the top line amid current near-zero interest rates.

Glaxo’s (GSK) Cancer Pipeline Grows Amid Rising Competition

The Zacks analyst is encouraged by the company’s initiatives to focus on its oncology pipeline. However, competitive pressure on its HIV and respiratory drugs is rising.

Strategic Initiatives Aid Anthem (ANTM), Rising Costs Hurt

Per the Zacks analyst, a number of acquisitions and collaborations have helped it enhance its capabilities and boost its Medicare business.

E-commerce Growth Helps FedEx (FDX), Despite Steep Costs

The Zacks analyst believes that the surge in e-commerce demand in the current scenario is a huge positive. However, high operating expenses are limiting bottom-line growth.

Expanding Cloud Portfolio & Partner Base Aids VMWare (VMW)

Per the Zacks analyst, VMware is benefiting from strong demand for its expanding cloud-based solutions, strong partner base, and Carbon Black & Pivotal acquisitions.

YUM! Brands (YUM) Banks on Digital Efforts Amid High Costs

Per the Zacks analyst, YUM! Brands increased focus on digital initiatives and refranchising efforts bode well.

New Upgrades

WestRock (WRK) Bets on E-Commerce Demand & Acquisitions

Per the Zacks analyst, WestRock will gain on pandemic-driven robust e-commerce demand.

Outsourcing & Leasing Pipeline Aid Jones Lang LaSalle (JLL)

Per the Zacks analyst, evolving outsourcing trends, improvement in pipelines in both leasing and capital markets, and healthy balance-sheet strength augur well for Jones Lang LaSalle.

Strong Underwriting , Cost Control Aid Amerisafe (AMSF)

Per the Zacks analyst, the company’s focus on loss control and safety programs as well as active claims management generates strong underwriting results, which leads to sustainable profitability.

New Downgrades

Sales Disruption Hits Thermo Fisher’s (TMO) Major End Market

The Zacks analyst is concerned about Thermo Fisher’s recent industrial and applied end market performance which is significantly affected by business disruptions due to the pandemic.

Lower Demand & Higher Costs to Hurt Crown Holdings (CCK)

The Zacks analyst is concerned that bleak demand in the transit packaging business owing to the coronavirus pandemic as well as higher raw material costs will impact Crown Holdings’ results.

Elevated Costs, Low Rates Hurt Interactive Brokers (IBKR)

Per the Zacks analyst, higher costs because of investments in technology upgrades will likely hamper Interactive Brokers’ profits. Its top line might be hurt due to near-zero interest rates.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Walmart Inc. (WMT) : Free Stock Analysis Report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Morgan Stanley (MS) : Free Stock Analysis Report
 
Intel Corporation (INTC) : Free Stock Analysis Report
 
GlaxoSmithKline plc (GSK) : Free Stock Analysis Report
 
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Read More

Add Comment

Click here to post a comment